PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$26.35
−0.94%Leverage
- Debt / equity
- 0.61x
- Net debt / equity
- 0.31x
- Debt / assets
- 0.33x
- Debt / EBITDA
- 3.59x
- Net debt / EBITDA
- 1.80x
Liquidity & coverage
- Current ratio
- 5.04x
- Quick ratio
- 3.94x
- Cash ratio
- 2.06x
- Interest coverage
- 1.33x
- EBITDA / interest
- 8.30x
- Working capital
- $493.2M
Cash & dividend
- FCF / debt
- 0.44x
- Cash flow / debt
- 0.46x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026